Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04164446Phase 1Unknown
Phase 1, randomised, double-blind trial (4 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoints: Fasting Plasma LDL Cholesterol level at Day 60 and Incidence of Adverse Events at Day 60. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04164446.